Home » Topics » Regulatory » Patents

Patents
RSS

Novel T-type calcium channel inhibitors discovered by Merck & Co. researchers

Feb. 5, 2009

Novel cannabinoid CB1 receptor antagonists discovered at Schering-Plough

Feb. 5, 2009

New PAI-1 inhibitors claimed by Kowa for treating thrombotic disorders

Feb. 5, 2009

Boehringer Ingelheim claims new oncolytic PI3K inhibitors in recent patent

Feb. 5, 2009

Recent sanofi-aventis patent reports new adenosine A3 receptor antagonists

Feb. 4, 2009

Otsuka discloses novel prodrugs of tolvaptan

Feb. 4, 2009

AstraZeneca scientists present new GABA-A2 receptor agonists with antipsychotic activity

Feb. 4, 2009

AstraZeneca and Astex scientists jointly impart novel BACE inhibitors

Feb. 4, 2009

Roche scientists claim Aurora kinase inhibitors and their use in cancer therapy

Feb. 4, 2009

New DPP-4 inhibitors discovered by Santhera and Biovitrum researchers

Feb. 3, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...